Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation
Saved in:
| Main Author: | Enes Ucgul MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748251318393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation
by: Erkan Topkan MD, et al.
Published: (2025-01-01) -
Prognostic and Predictive Value of Pan-Immune Inflammation Value in Rectal Cancer Patients Treated With Neoadjuvant Therapy
by: Aybala Nur Ucgul MD, et al.
Published: (2025-07-01) -
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer
by: Lisa Paschold, et al.
Published: (2025-08-01) -
Predictive Effect of Systemic Immune-Inflammation Index on Immunotherapy in Patients With Advanced Non-Small Cell Lung Cancer
by: Fubin Feng MD, et al.
Published: (2025-06-01) -
Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation
by: Aybala Nur Ucgul, et al.
Published: (2025-07-01)